Daewoong Pharm BTX set to face import ban in US
Posted : 2020-12-17 17:12
By Kim Jae-heun
The U.S. International Trade Commission (ITC), Thursday, ruled in favor of Medytox over Daewoong Pharmaceutical in its final decision to ban the latter from exporting its botulinum products to the U.S. for almost two years. Daewoong Pharmaceutical s botulinum toxin strain Nabota is believed to be in violation of Article 337 of the Customs Act and we order it to be banned from importing to the United States for 21 months, the ITC ruled.
The ITC also prohibited Daewoong s global partner Evolus from selling its stock of the drug, which is marketed under the name Jeuveau there. If Evolus wants to import or sell Jeuveau while the U.S. president is reviewing the ITC s decision, it must pay $441 per vial for deposit.
ITC Favors Medytox over Daewoong in Botulinum Toxin Strain Dispute in Final Ruling koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
WASHINGTON, Dec. 16, 2020 /PRNewswire/ Blueberry growers across America today established a new coalition, the American Blueberry Growers Alliance, to seek relief from rising imports that are harming their businesses. The Alliance will provide information and support to an ongoing U.S. International Trade Commission (ITC) investigation into the serious injury caused by increased imports of fresh, chilled and frozen blueberries under Section 201 of the Trade Act of 1974.
Blueberry imports are sourced from several countries in the Western Hemisphere. Imports rose by more than 60 percent between 2015 and 2019. Imports from Peru and Mexico have increased by 1,258 and 268 percent during that same period, respectively, driving blueberry prices down by double digits, which has had a devastating impact on the domestic blueberry industry.
U S imports from China surge in 2020 despite tariffs, pandemic: media - Xinhua xinhuanet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from xinhuanet.com Daily Mail and Mail on Sunday newspapers.
ADVERTISEMENT
ADVERTISEMENT
Korean Co. Joins Garmin s Bid To Keep ITC, PTAB Separate
Law360 (December 14, 2020, 11:27 PM EST) South Korea s largest petrochemical company has thrown its weight behind Garmin and Fitbit s request that the Patent Trial and Appeal Board s precedent-setting panel forbid the board from weighing the timing of U.S. International Trade Commission investigations when deciding whether to review a patent.
SK Innovation s amicus brief says the Fintiv factors, which the PTAB uses to decide whether co-pending proceedings in other tribunals justify not reviewing a patent, should exclude the ITC. The Dec. 9 brief to the PTAB s Precedential Opinion Panel, which was made public on Monday, stresses that the ITC does not have the authority to invalidate patents..